US Venture Partners X L.P., 10% Owner at eFFECTOR Therapeutics, Inc. (EFTR), sold 69,641 shares at $1.00 ($76K) on 2022-07-19, disclosed to the SEC on 2022-07-19.
Open-market sale of $76k EFTR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.11 | 1,423 | $2K | 2.1% |
| 2 | $1.11 | 44,477 | $49K | 64.6% |
| 3 | $1.08 | 635 | $686 | 0.9% |
| 4 | $1.08 | 20,352 | $22K | 28.8% |
| 5 | $1.00 | 84 | $84 | 0.1% |
| 6 | $1.00 | 2,670 |
| $3K |
| 3.5% |
| Total | $1.10 avg | 69,641 | $76K | 100% |
| Filing → |
| EFTR | SELL | 2021-12-06 | $46K | — | Filing → |
| EFTR | SELL | 2021-11-26 | $781K | — | Filing → |
| NARI | BUY | 2020-05-27 | $1.9M | — | Filing → |